Elite Journal of Health Sciences. Volume 2 issue 2(2024), Pp. 40-49 https://epjournals.com/journals/EJHS Citation: Obeagu EI, Ogbu ISI, Obeagu GU. Hemoglobin Dynamics: Unraveling the Role in Monitoring Breast Cancer Evolution. Elite Journal of Health Science, 2024; 2(2): 40-49 1 Hemoglobin Dynamics: Unraveling the Role in Monitoring Breast Cancer Evolution * Emmanuel Ifeanyi Obeagu1, I.S.I Ogbu 2 and Getrude Uzoma Obeagu 3 1 Department of Medical Laboratory Science, Kampala International University, Uganda 2 School of Nursing Science, Kampala International University, Uganda 3 Department of Medical Laboratory Science, Evangel University Akaeze, Ebonyi State, Nigeria. * Corresponding authour: Emmanuel Ifeanyi Obeagu, Department of Medical Laboratory Science, Kampala International University, Uganda, emmanuelobeagu@yahoo.com, ORCID: 0000-0002- 4538-0161 Abstract Breast cancer remains a complex and multifaceted disease, necessitating the identification of novel biomarkers for effective monitoring of its evolution. This paper explores the evolving role of hemoglobin variations as a potential indicator in understanding and tracking breast cancer progression. Hemoglobin, primarily recognized for its oxygen transport function, has emerged as a promising biomarker due to its dynamic alterations within the tumor microenvironment. Through an extensive synthesis of current literature, this review elucidates the intricate relationship between hemoglobin fluctuations and breast cancer evolution. It discusses the molecular mechanisms underlying hemoglobin modifications, their correlation with tumor characteristics, and their clinical implications for disease monitoring. Furthermore, it outlines the diagnostic potential of hemoglobin indices in guiding treatment strategies, predicting patient outcomes, and enhancing personalized medicine in breast cancer management. However, challenges persist in standardizing measurement techniques and interpreting hemoglobin variations accurately. This review also identifies these limitations and proposes future research directions to optimize the clinical utility of hemoglobin as a biomarker for monitoring breast cancer evolution. In conclusion, understanding the significance of hemoglobin dynamics offers a promising avenue for refining prognostication, treatment assessment, and improving overall outcomes in breast cancer patients. Keywords: Hemoglobin, Breast Cancer, Tumor Microenvironment, Disease Evolution, Biomarkers, Clinical Implications, Precision Medicine Introduction